Regulatory and clinical perspective on patient access to antidiabetic medicines in Slovenia
Introduction/Objective. Three novel classes of antidiabetic medicines have been introduced into the market in the last decade, namely dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium-glucose co-transporter 2 inhibitors. Many factors influence patient access to...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Serbian Medical Society
2021-01-01
|
| Series: | Srpski Arhiv za Celokupno Lekarstvo |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2021/0370-81792100058Z.pdf |